[Serum polypeptides in peptic ulcer patients]
Abstract:
Fifty-four healthy subjects and 56 peptic ulcer patients were examined for blood serum polypeptides, their toxicity and antigenicity. It was discovered that in the peptic ulcer patients, the blood polypeptide content was 1.5-3-fold higher than in healthy subjects. The increased content of polypeptides in the patients was caused by a high supply of polypeptides from the gastrointestinal tract. Polypeptides isolated from the patients' blood had toxic and antigenic properties. Antibodies against polypeptides were detected in 82% of the peptic ulcer patients and in 10% of the healthy persons. A direct correlation was found between the titer of antibodies against polypeptides and IgG content. It is suggested that polypeptides are involved in the development of peptic ulcer.
Related Concept Videos
Pathophysiology of Peptic Ulcer Disease: Injurious Factors
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds to M3...
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
Peptic Ulcer Disease I: Introduction
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Peptic Ulcer
Peptic Ulcer Disease I: Introduction


